Protagonist Therapeutics Inc buy BTIG Research
Start price
24.07.24
/
50%
€21.80
Target price
24.07.25
€46.93
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 24.07.25. The prediction end date can be changed by BTIG_Research at any time.Performance without dividends (%)
Name | 1w |
---|---|
Protagonist Therapeutics Inc | - |
iShares Core DAX® | -0.116% |
iShares Nasdaq 100 | -2.733% |
iShares Nikkei 225® | -1.721% |
iShares S&P 500 | -1.527% |
Comments by BTIG_Research for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at BTIG Research from $41.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat